BackOpus Genetics Overview

Opus Genetics Accounts Payable

Track Opus Genetics's accounts payable ($3.7M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$3.73M
↑ 55.62% YoYΔ $1.33M vs prior year quarter

Peer trimmed avg / median

Loading

Opus Genetics Accounts Payable History

Loading

Opus Genetics vs. peers: Accounts Payable Comparison

Loading

Opus Genetics Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Opus Genetics (IRD) FAQ

As of the most recent data (September 2026), IRD shows a accounts payable of $3.7M. That compares with $2.4M in the prior-year period — up 55.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IRD's accounts payable is now $3.7M (was $2.4M) — a 55.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Opus Genetics is outperforming or lagging.

Tracking IRD's accounts payable over time shows whether Opus Genetics is scaling, shrinking, or reshaping that part of the business. The current reading is $3.7M That compares with $2.4M in the prior-year period — up 55.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Opus Genetics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.7M) with ownership activity and broader fundamentals.

Opus Genetics's accounts payable is $3.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.